metoprolol succinate - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
MINAX XL metoprolol succinate 190 mg modified release tablet blister pack AUST R: 205150 Active ingredients: metoprolol succinate Dosage form: Tablet, modified release Sponsor: Alphapharm Pty Ltd Phone: 1800274276	From 27 Nov 2024 to 30 Sep 2025	Shortage status: Current Availability: Unavailable Reason: Manufacturing Management action: Alternative generic products are available.
MINAX XL metoprolol succinate 23.75 mg modified release tablet blister pack AUST R: 205151 Active ingredients: metoprolol succinate Dosage form: Tablet, modified release Sponsor: Alphapharm Pty Ltd Phone: 1800274276	From 07 Apr 2025 to 30 Sep 2025	Shortage status: Current Availability: Limited Availability Reason: Manufacturing Management action: Alternative generic products are available.
MINAX XL metoprolol succinate 47.5 mg modified release tablet blister pack AUST R: 205149 Active ingredients: metoprolol succinate Dosage form: Tablet, modified release Sponsor: Alphapharm Pty Ltd Phone: 1800274276	From 16 Jan 2025 to 30 Sep 2025	Shortage status: Current Availability: Unavailable Reason: Manufacturing Management action: Alternative generic products are available.
MINAX XL metoprolol succinate 95 mg modified release tablet blister pack AUST R: 205148 Active ingredients: metoprolol succinate Dosage form: Tablet, modified release Sponsor: Alphapharm Pty Ltd Phone: 1800274276	From 31 Jan 2025 to 30 Sep 2025	Shortage status: Current Availability: Limited Availability Reason: Manufacturing Management action: Alternative generic products are available.